#Pharma #Semaglutide #HealthcareIndia #GLP1 #GenericDrugs #PharmaNews #IndiaManufacturing #DiabetesCare To view or add a comment, sign in The GLP-1 Wave & What It Means for Indian Pharma I watched a breakdown by Avani Anchalia & read a Substack post by Akhilesh Gururani, and followed it up with the latest news around Emcure's Poviztra price cut and the picture that emerged is exciting
The exact amount depends on your goals, health, and provider
To investigate whether ATP was contained in GLP-1 containing vesicles, we first attempted to perform co-staining for quinacrine and GLP-1, but the permeabilisation and fixation protocols needed for immunofluorescence staining were incompatible with quinacrine staining for ATP
As a result, these agents may influence sympathetic and parasympathetic tone
Conditions with strong preclinical evidence such as tendon injuries, gastric ulcers, and inflammatory bowel disease represent logical initial targets for clinical investigation